HEADER HYDROLASE 18-JAN-06 2FQQ TITLE CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS285->ALA, CYS362->ALA, TITLE 2 CYS364->ALA, CYS397->ALA) IN COMPLEX WITH 1-METHYL-3-TRIFLUOROMETHYL- TITLE 3 1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P20 SUBUNIT, RESIDUES 120-297; COMPND 5 EC: 3.4.22.36; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CASPASE-1; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: P10 SUBUNIT, RESIDUES 317-404; COMPND 12 EC: 3.4.22.36; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP1, IL1BC, IL1BCE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON+; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSET; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CASP1, IL1BC, IL1BCE; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON+; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PRSET KEYWDS CASPASE, ALLOSTERIC INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.SCHEER,J.A.WELLS,M.J.ROMANOWSKI REVDAT 5 30-AUG-23 2FQQ 1 REMARK REVDAT 4 20-OCT-21 2FQQ 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 2FQQ 1 VERSN REVDAT 2 24-FEB-09 2FQQ 1 VERSN REVDAT 1 16-MAY-06 2FQQ 0 JRNL AUTH J.M.SCHEER,M.J.ROMANOWSKI,J.A.WELLS JRNL TITL A COMMON ALLOSTERIC SITE AND MECHANISM IN CASPASES JRNL REF PROC.NATL.ACAD.SCI.USA V. 103 7595 2006 JRNL REFN ISSN 0027-8424 JRNL PMID 16682620 JRNL DOI 10.1073/PNAS.0602571103 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 5225 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 247 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.41 REMARK 3 REFLECTION IN BIN (WORKING SET) : 526 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.28 REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE SET COUNT : 23 REMARK 3 BIN FREE R VALUE : 0.2680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1861 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 18 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.51000 REMARK 3 B22 (A**2) : 4.51000 REMARK 3 B33 (A**2) : -6.77000 REMARK 3 B12 (A**2) : 2.26000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.567 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.464 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 62.137 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.896 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.817 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1922 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2596 ; 1.119 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 233 ; 3.259 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 86 ;35.744 ;23.721 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 340 ;15.756 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;10.942 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 286 ; 0.042 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1442 ; 0.001 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 813 ; 0.123 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1310 ; 0.284 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 66 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 59 ; 0.071 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.165 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 1 REMARK 3 ORIGIN FOR THE GROUP (A): 41.0054 28.1484 34.1417 REMARK 3 T TENSOR REMARK 3 T11: -0.0336 T22: 0.0431 REMARK 3 T33: 0.0474 T12: -0.0256 REMARK 3 T13: -0.0790 T23: -0.0631 REMARK 3 L TENSOR REMARK 3 L11: 2.0237 L22: 2.3744 REMARK 3 L33: 3.4920 L12: 0.5489 REMARK 3 L13: -0.0107 L23: -0.3812 REMARK 3 S TENSOR REMARK 3 S11: 0.1940 S12: 0.1254 S13: -0.2335 REMARK 3 S21: 0.1190 S22: -0.0511 S23: -0.0197 REMARK 3 S31: 0.3250 S32: -0.1542 S33: -0.1428 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FQQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000036197. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5490 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1SC1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MM HEPES, 16.5% PEG 3350, 250 MM REMARK 280 (NH4)2SO4, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.50733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.25367 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.25367 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 78.50733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: HETEROTETRAMER (DIMER OF TWO HETERODIMERS). EACH REMARK 300 HETERODIMER IS REPRESENTED BY CHAINS A (THE P20 SUBUNIT) AND B (THE REMARK 300 P10 SUBUNIT) OF HUMAN CASPASE-1. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 13870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -76.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 106.56600 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 61.52591 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 78.50733 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 120 REMARK 465 PRO A 121 REMARK 465 ALA A 122 REMARK 465 MET A 123 REMARK 465 PRO A 124 REMARK 465 THR A 125 REMARK 465 SER A 126 REMARK 465 SER A 127 REMARK 465 GLY A 128 REMARK 465 SER A 129 REMARK 465 GLU A 130 REMARK 465 GLY A 131 REMARK 465 ASN A 132 REMARK 465 VAL A 133 REMARK 465 LYS A 134 REMARK 465 LEU A 135 REMARK 465 CYS A 136 REMARK 465 SER A 137 REMARK 465 LEU A 138 REMARK 465 GLU A 139 REMARK 465 GLU A 140 REMARK 465 ALA A 141 REMARK 465 GLN A 142 REMARK 465 ARG A 143 REMARK 465 ILE A 144 REMARK 465 TRP A 145 REMARK 465 LYS A 146 REMARK 465 GLN A 147 REMARK 465 LYS A 148 REMARK 465 SER A 149 REMARK 465 ALA A 150 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 240 CB CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 205 83.33 51.20 REMARK 500 ILE A 239 -163.78 -124.60 REMARK 500 PRO A 290 125.59 -31.36 REMARK 500 HIS B 342 79.06 59.33 REMARK 500 SER B 363 -31.69 -148.39 REMARK 500 ASP B 381 -43.77 -138.80 REMARK 500 PHE B 401 85.65 58.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE F1G B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SC1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN REMARK 900 CASPASE-1 C285A MUTANT REMARK 900 RELATED ID: 1SC3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX REMARK 900 WITH MALONATE REMARK 900 RELATED ID: 1SC4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT AFTER REMOVAL REMARK 900 OF MALONATE REMARK 900 RELATED ID: 2FQR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF WILDTYPE HUMAN CASPASE-1 IN COMPLEX WITH 3-(2-{ REMARK 900 2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3-METHYL- REMARK 900 BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4-TRIOL (Z-VAD-FMK) REMARK 900 RELATED ID: 2FQS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA) IN COMPLEX WITH REMARK 900 3-(2-{2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3- REMARK 900 METHYL-BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4-TRIOL (Z- REMARK 900 VAD-FMK) REMARK 900 RELATED ID: 2FQU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ALA) IN COMPLEX WITH REMARK 900 3-(2-{2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3- REMARK 900 METHYL-BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4-TRIOL (Z- REMARK 900 VAD-FMK) REMARK 900 RELATED ID: 2FQV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA, GLU390->ALA) IN REMARK 900 COMPLEX WITH 3-(2-{2-[(CYCLOHEXYLMETHOXY-HYDROXY-METHYL)-AMINO]-1- REMARK 900 HYDROXY-3-METHYL-BUTYLAMINO}-1-HYDROXY-PROPYLAMINO)-PENTANE-1,1,4- REMARK 900 TRIOL (Z-VAD-FMK) DBREF 2FQQ A 120 297 UNP P29466 CASP1_HUMAN 120 297 DBREF 2FQQ B 317 404 UNP P29466 CASP1_HUMAN 317 404 SEQADV 2FQQ ALA A 285 UNP P29466 CYS 285 ENGINEERED MUTATION SEQADV 2FQQ ALA B 362 UNP P29466 CYS 362 ENGINEERED MUTATION SEQADV 2FQQ ALA B 364 UNP P29466 CYS 364 ENGINEERED MUTATION SEQADV 2FQQ ALA B 397 UNP P29466 CYS 397 ENGINEERED MUTATION SEQRES 1 A 178 ASN PRO ALA MET PRO THR SER SER GLY SER GLU GLY ASN SEQRES 2 A 178 VAL LYS LEU CYS SER LEU GLU GLU ALA GLN ARG ILE TRP SEQRES 3 A 178 LYS GLN LYS SER ALA GLU ILE TYR PRO ILE MET ASP LYS SEQRES 4 A 178 SER SER ARG THR ARG LEU ALA LEU ILE ILE CYS ASN GLU SEQRES 5 A 178 GLU PHE ASP SER ILE PRO ARG ARG THR GLY ALA GLU VAL SEQRES 6 A 178 ASP ILE THR GLY MET THR MET LEU LEU GLN ASN LEU GLY SEQRES 7 A 178 TYR SER VAL ASP VAL LYS LYS ASN LEU THR ALA SER ASP SEQRES 8 A 178 MET THR THR GLU LEU GLU ALA PHE ALA HIS ARG PRO GLU SEQRES 9 A 178 HIS LYS THR SER ASP SER THR PHE LEU VAL PHE MET SER SEQRES 10 A 178 HIS GLY ILE ARG GLU GLY ILE CYS GLY LYS LYS HIS SER SEQRES 11 A 178 GLU GLN VAL PRO ASP ILE LEU GLN LEU ASN ALA ILE PHE SEQRES 12 A 178 ASN MET LEU ASN THR LYS ASN CYS PRO SER LEU LYS ASP SEQRES 13 A 178 LYS PRO LYS VAL ILE ILE ILE GLN ALA ALA ARG GLY ASP SEQRES 14 A 178 SER PRO GLY VAL VAL TRP PHE LYS ASP SEQRES 1 B 88 ALA ILE LYS LYS ALA HIS ILE GLU LYS ASP PHE ILE ALA SEQRES 2 B 88 PHE CYS SER SER THR PRO ASP ASN VAL SER TRP ARG HIS SEQRES 3 B 88 PRO THR MET GLY SER VAL PHE ILE GLY ARG LEU ILE GLU SEQRES 4 B 88 HIS MET GLN GLU TYR ALA ALA SER ALA ASP VAL GLU GLU SEQRES 5 B 88 ILE PHE ARG LYS VAL ARG PHE SER PHE GLU GLN PRO ASP SEQRES 6 B 88 GLY ARG ALA GLN MET PRO THR THR GLU ARG VAL THR LEU SEQRES 7 B 88 THR ARG ALA PHE TYR LEU PHE PRO GLY HIS HET F1G B 1 19 HETNAM F1G 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5- HETNAM 2 F1G CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE FORMUL 3 F1G C10 H10 F3 N3 O S2 FORMUL 4 HOH *18(H2 O) HELIX 1 1 ASP A 157 ARG A 161 5 5 HELIX 2 2 GLY A 181 LEU A 196 1 16 HELIX 3 3 THR A 207 HIS A 220 1 14 HELIX 4 4 ARG A 221 SER A 227 5 7 HELIX 5 5 LEU A 258 ASN A 263 1 6 HELIX 6 6 CYS A 270 LYS A 274 5 5 HELIX 7 7 SER B 347 TYR B 360 1 14 HELIX 8 8 ASP B 365 PHE B 377 1 13 SHEET 1 A 6 SER A 199 LYS A 204 0 SHEET 2 A 6 LEU A 164 CYS A 169 1 N ILE A 167 O ASP A 201 SHEET 3 A 6 THR A 230 HIS A 237 1 O VAL A 233 N ILE A 168 SHEET 4 A 6 LYS A 278 ALA A 285 1 O VAL A 279 N LEU A 232 SHEET 5 A 6 PHE B 327 SER B 332 1 O ILE B 328 N ILE A 280 SHEET 6 A 6 PRO B 387 GLU B 390 -1 O GLU B 390 N ALA B 329 SHEET 1 B 2 GLY A 242 CYS A 244 0 SHEET 2 B 2 ILE A 255 GLN A 257 -1 O LEU A 256 N ILE A 243 LINK S1 F1G B 1 SG CYS B 331 1555 1555 1.81 SITE 1 AC1 6 LEU A 258 PHE A 262 ARG A 286 CYS B 331 SITE 2 AC1 6 GLU B 390 ARG B 391 CRYST1 71.044 71.044 117.761 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014076 0.008127 0.000000 0.00000 SCALE2 0.000000 0.016253 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008492 0.00000